Preoperative increased systemic immune-inflammation index predicts poor prognosis in patients with operable non-small cell lung cancer
- 31 May 2018
- journal article
- research article
- Published by Elsevier BV in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 484, 272-277
- https://doi.org/10.1016/j.cca.2018.05.059
Abstract
No abstract availableKeywords
Funding Information
- Tumor transformation medicine seed Foundation of Tianjin Medical University Cancer Institute and Hospital (Grant No.1613)
- Wu Jieping Medical Foundation (320.6750.17519)
- Doctoral Foundation of Tianjin Medical University Cancer Institute and Hospital (B1502)
This publication has 25 references indexed in Scilit:
- Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non‐small cell lung cancer patientsThoracic Cancer, 2015
- Systemic Immune-Inflammation Index Predicts Prognosis of Patients after Curative Resection for Hepatocellular CarcinomaClinical Cancer Research, 2014
- Prognostic significance of neutrophil lymphocyte ratio and platelet lymphocyte ratio in advanced gastric cancer patients treated with FOLFOX chemotherapyBMC Cancer, 2013
- Platelets and Tumor Cells: A New Form of Border ControlCancer Cell, 2013
- Treatment of Stage I and II Non-small Cell Lung CancerSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Dual Roles for Immunity in Gastrointestinal CancersJournal of Clinical Oncology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Timing of Local and Distant Failure in Resected Lung Cancer: Implications for Reported Rates of Local FailureJournal of Thoracic Oncology, 2010
- Systemic inflammation, nutritional status and survival in patients with cancerCurrent Opinion in Clinical Nutrition and Metabolic Care, 2009
- Cancer-related inflammationNature, 2008